{"id":4555,"date":"2020-10-29T07:00:25","date_gmt":"2020-10-29T06:00:25","guid":{"rendered":"https:\/\/www.ab-science.com\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\/"},"modified":"2021-01-20T13:53:02","modified_gmt":"2021-01-20T12:53:02","slug":"financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle","status":"publish","type":"post","link":"https:\/\/www.ab-science.com\/fr\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\/","title":{"rendered":"Financement de 4,5 millions d\u2019euros par \u00e9mission d\u2019obligations convertibles en actions ordinaires nouvelle"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column][vc_column_text]29\/10\/2020 &#8211; AB Science S.A. annonce avoir conclu, avec des investisseurs qualifi\u00e9s, un accord portant sur un financement de 4,5 millions d\u2019euros par \u00e9mission d\u2019obligations convertibles en actions ordinaires nouvelles (les \u00ab OCA \u00bb) auxquelles sont attach\u00e9s des bons de souscription d\u2019actions (les \u00ab BSA \u00bb et, avec les OCA, les \u00ab OCABSA \u00bb).[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column]<iframe width=\"100%\" height=\"800\" src=\"https:\/\/www.ab-science.com\/themencode-pdf-viewer-sc\/?tnc_pvfw=ZmlsZT1odHRwczovL3d3dy5hYi1zY2llbmNlLmNvbS93cC1jb250ZW50L3VwbG9hZHMvMjAyMS8wMS8yMDIwMTAyOS1BSy1PY3RvYnJlLTIwMjBfQUItU2NpZW5jZS1DUC1vY3RvYnJlLTIwMjAtVkZSLVZGLnBkZiZzZXR0aW5ncz0xMTEwMTExMTExMTExMTExMTAwJmxhbmc9ZW4tVVM=#page=&zoom=auto&pagemode=none\" title=\"\"><\/iframe>[\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text]29\/10\/2020 &#8211; AB Science S.A. annonce avoir conclu, avec des investisseurs qualifi\u00e9s, un accord portant sur un financement de 4,5 millions d\u2019euros par \u00e9mission d\u2019obligations convertibles en actions ordinaires nouvelles (les \u00ab OCA \u00bb) auxquelles sont attach\u00e9s des bons de souscription d\u2019actions (les \u00ab BSA \u00bb et, avec les OCA, les \u00ab OCABSA \u00bb).[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[79],"tags":[],"class_list":["post-4555","post","type-post","status-publish","format-standard","hentry","category-2020-fr","category-79","description-off"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Financement de 4,5 millions d\u2019euros sous forme d\u2019obligations convertibles en actions<\/title>\n<meta name=\"description\" content=\"AB Science annonce avoir conclu, avec des investisseurs qualifi\u00e9s, un accord portant sur un financement de 4,5 millions d\u2019euros par \u00e9mission d\u2019obligations convertibles en actions ordinaires nouvelles (les \u00ab OCA \u00bb) auxquelles sont attach\u00e9s des bons de souscription d\u2019actions (les \u00ab BSA \u00bb et, avec les OCA, les \u00ab OCABSA \u00bb).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ab-science.com\/fr\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Financement de 4,5 millions d\u2019euros par \u00e9mission d\u2019obligations convertibles en actions ordinaires nouvelle\" \/>\n<meta property=\"og:description\" content=\"AB Science annonce avoir conclu, avec des investisseurs qualifi\u00e9s, un accord portant sur un financement de 4,5 millions d\u2019euros par \u00e9mission d\u2019obligations convertibles en actions ordinaires nouvelles (les \u00ab OCA \u00bb) auxquelles sont attach\u00e9s des bons de souscription d\u2019actions (les \u00ab BSA \u00bb et, avec les OCA, les \u00ab OCABSA \u00bb).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ab-science.com\/fr\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\/\" \/>\n<meta property=\"og:site_name\" content=\"AB Science\" \/>\n<meta property=\"article:published_time\" content=\"2020-10-29T06:00:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-01-20T12:53:02+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/person\\\/a6488ccf78f6ce38f56db0bb7228ffa6\"},\"headline\":\"Financement de 4,5 millions d\u2019euros par \u00e9mission d\u2019obligations convertibles en actions ordinaires nouvelle\",\"datePublished\":\"2020-10-29T06:00:25+00:00\",\"dateModified\":\"2021-01-20T12:53:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\\\/\"},\"wordCount\":103,\"publisher\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#organization\"},\"articleSection\":[\"2020\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\\\/\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\\\/\",\"name\":\"Financement de 4,5 millions d\u2019euros sous forme d\u2019obligations convertibles en actions\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#website\"},\"datePublished\":\"2020-10-29T06:00:25+00:00\",\"dateModified\":\"2021-01-20T12:53:02+00:00\",\"description\":\"AB Science annonce avoir conclu, avec des investisseurs qualifi\u00e9s, un accord portant sur un financement de 4,5 millions d\u2019euros par \u00e9mission d\u2019obligations convertibles en actions ordinaires nouvelles (les \u00ab OCA \u00bb) auxquelles sont attach\u00e9s des bons de souscription d\u2019actions (les \u00ab BSA \u00bb et, avec les OCA, les \u00ab OCABSA \u00bb).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Financement de 4,5 millions d\u2019euros par \u00e9mission d\u2019obligations convertibles en actions ordinaires nouvelle\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"name\":\"AB Science\",\"description\":\"Masitinib and AB8939 \u2013 Two compounds with breakthrough mechanism of action\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#organization\",\"name\":\"AB Science\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/logo_ab-science-wh120.png\",\"contentUrl\":\"https:\\\/\\\/www.ab-science.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/logo_ab-science-wh120.png\",\"width\":120,\"height\":120,\"caption\":\"AB Science\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ab-science\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/person\\\/a6488ccf78f6ce38f56db0bb7228ffa6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/37434bc9f38884ed0b9fe0f34bc67ecc3858ae54e6ff3d90e3c112864996eca0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/37434bc9f38884ed0b9fe0f34bc67ecc3858ae54e6ff3d90e3c112864996eca0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/37434bc9f38884ed0b9fe0f34bc67ecc3858ae54e6ff3d90e3c112864996eca0?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/ab-science.excalibra.com\"],\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/author\\\/antoine_f6vzo0vn\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Financement de 4,5 millions d\u2019euros sous forme d\u2019obligations convertibles en actions","description":"AB Science annonce avoir conclu, avec des investisseurs qualifi\u00e9s, un accord portant sur un financement de 4,5 millions d\u2019euros par \u00e9mission d\u2019obligations convertibles en actions ordinaires nouvelles (les \u00ab OCA \u00bb) auxquelles sont attach\u00e9s des bons de souscription d\u2019actions (les \u00ab BSA \u00bb et, avec les OCA, les \u00ab OCABSA \u00bb).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ab-science.com\/fr\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\/","og_locale":"fr_FR","og_type":"article","og_title":"Financement de 4,5 millions d\u2019euros par \u00e9mission d\u2019obligations convertibles en actions ordinaires nouvelle","og_description":"AB Science annonce avoir conclu, avec des investisseurs qualifi\u00e9s, un accord portant sur un financement de 4,5 millions d\u2019euros par \u00e9mission d\u2019obligations convertibles en actions ordinaires nouvelles (les \u00ab OCA \u00bb) auxquelles sont attach\u00e9s des bons de souscription d\u2019actions (les \u00ab BSA \u00bb et, avec les OCA, les \u00ab OCABSA \u00bb).","og_url":"https:\/\/www.ab-science.com\/fr\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\/","og_site_name":"AB Science","article_published_time":"2020-10-29T06:00:25+00:00","article_modified_time":"2021-01-20T12:53:02+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ab-science.com\/fr\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\/#article","isPartOf":{"@id":"https:\/\/www.ab-science.com\/fr\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\/"},"author":{"name":"admin","@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/person\/a6488ccf78f6ce38f56db0bb7228ffa6"},"headline":"Financement de 4,5 millions d\u2019euros par \u00e9mission d\u2019obligations convertibles en actions ordinaires nouvelle","datePublished":"2020-10-29T06:00:25+00:00","dateModified":"2021-01-20T12:53:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ab-science.com\/fr\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\/"},"wordCount":103,"publisher":{"@id":"https:\/\/www.ab-science.com\/fr\/#organization"},"articleSection":["2020"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.ab-science.com\/fr\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\/","url":"https:\/\/www.ab-science.com\/fr\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\/","name":"Financement de 4,5 millions d\u2019euros sous forme d\u2019obligations convertibles en actions","isPartOf":{"@id":"https:\/\/www.ab-science.com\/fr\/#website"},"datePublished":"2020-10-29T06:00:25+00:00","dateModified":"2021-01-20T12:53:02+00:00","description":"AB Science annonce avoir conclu, avec des investisseurs qualifi\u00e9s, un accord portant sur un financement de 4,5 millions d\u2019euros par \u00e9mission d\u2019obligations convertibles en actions ordinaires nouvelles (les \u00ab OCA \u00bb) auxquelles sont attach\u00e9s des bons de souscription d\u2019actions (les \u00ab BSA \u00bb et, avec les OCA, les \u00ab OCABSA \u00bb).","breadcrumb":{"@id":"https:\/\/www.ab-science.com\/fr\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ab-science.com\/fr\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ab-science.com\/fr\/financement-de-45-millions-deuros-par-emission-dobligations-convertibles-en-actions-ordinaires-nouvelle\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.ab-science.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Financement de 4,5 millions d\u2019euros par \u00e9mission d\u2019obligations convertibles en actions ordinaires nouvelle"}]},{"@type":"WebSite","@id":"https:\/\/www.ab-science.com\/fr\/#website","url":"https:\/\/www.ab-science.com\/fr\/","name":"AB Science","description":"Masitinib and AB8939 \u2013 Two compounds with breakthrough mechanism of action","publisher":{"@id":"https:\/\/www.ab-science.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ab-science.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ab-science.com\/fr\/#organization","name":"AB Science","url":"https:\/\/www.ab-science.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ab-science.com\/wp-content\/uploads\/2020\/11\/logo_ab-science-wh120.png","contentUrl":"https:\/\/www.ab-science.com\/wp-content\/uploads\/2020\/11\/logo_ab-science-wh120.png","width":120,"height":120,"caption":"AB Science"},"image":{"@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/ab-science\/"]},{"@type":"Person","@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/person\/a6488ccf78f6ce38f56db0bb7228ffa6","name":"admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/37434bc9f38884ed0b9fe0f34bc67ecc3858ae54e6ff3d90e3c112864996eca0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/37434bc9f38884ed0b9fe0f34bc67ecc3858ae54e6ff3d90e3c112864996eca0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/37434bc9f38884ed0b9fe0f34bc67ecc3858ae54e6ff3d90e3c112864996eca0?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/ab-science.excalibra.com"],"url":"https:\/\/www.ab-science.com\/fr\/author\/antoine_f6vzo0vn\/"}]}},"_links":{"self":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/posts\/4555","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/comments?post=4555"}],"version-history":[{"count":0,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/posts\/4555\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/media?parent=4555"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/categories?post=4555"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/tags?post=4555"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}